In a major shift in federal drug policy, President Donald Trump signed an executive order (EO), directing the attorney general to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). While this change does not legalize cannabis federally, it will, once finalized, significantly ease research barriers and could lay the groundwork for expanded patient access and state–federal alignment.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jim
Contact Jim, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack